Intouch Solutions

OCTOBER 13, 2023

Pharmaceutical companies can sponsor as well as provide these leaders. Pharmaceutical companies can increase diversity in their clinical trials. Companies can also support pre-existing SDOH research initiatives. Studies should include as detailed SDOH data as possible.

Pharma Companies 105

Pharma Companies Clinical Trials Clinical Trials Genetics 105

pharmaphorum

SEPTEMBER 2, 2020

The UK’s medicines regulator has published long-awaited guidance on regulation of medicines and medical devices as the UK approaches the end of its Brexit transition period at the end of the year. The concern is that UK patients will face delays to receiving the latest medicines because of the changes to the regulatory system.

Regulation 124

Regulation Medicine Pharma Companies Clinical Trials 124

Pharmaceutical Technology

FEBRUARY 24, 2023

The overhaul will address drug marketing exclusivity length, pricing, patient access, innovation incentives, antimicrobial resistance, clinical trials, supply chain security and shortages, and environmental impact. But others do not accept that the EU is less competitive for the pharma industry than North America and Asia.

Regulation 162

Regulation Clinical Trials Clinical Trials Medicine 162

XTalks

MAY 11, 2023

Clinical trials are essential for the development of new treatments for rare diseases, but they can be complex and challenging to execute. Patient input is a crucial component of rare disease clinical trials, as it can provide valuable insights into the patient experience and inform decisions about study design and implementation.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

pharmaphorum

JULY 14, 2022

A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52

Pharmaceutical Technology

JANUARY 16, 2023

Recent cases in the pharmaceutical sector include Poolbeg Pharma finding more than one respiratory syncytial virus (RSV) vaccine candidate with AI by going through a vast amount of early stage clinical data to prioritise candidates and reposition them as novel treatments for RSV infection.

Big Data 303

Big Data Pharma Companies Clinical Trials Clinical Trials 303

The Pharma Data

OCTOBER 16, 2020

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. BetterLife conducts patient centric study via a fully remote clinical trial.

In-Vitro 52

In-Vitro Clinical Trials Clinical Trials Trials 52

pharmaphorum

JANUARY 26, 2023

Guidance on the way pharma companies communicate about prescription medicines has been updated in the UK to cover use of social media channels for the first time. It has drawn up the guidance with the help of the companies, the ABPI, and UK regulator the MHRA.

Medicine 105

Medicine Pharma Companies Clinical Trials Clinical Trials 105

Pharmaceutical Technology

JULY 21, 2022

In 2010, only eight big pharma companies had an access strategy for low- and middle-income countries, but today, 17 of the biggest 20 companies do. In response to the Ukraine crisis, many pharma companies are ensuring a supply of essential medicine to Ukraine and surrounding countries.

Pharma Companies 130

Pharma Companies Clinical Trials Clinical Trials Drugs 130

Drug Discovery World

JANUARY 24, 2023

Virtual clinical trials ‘Virtual’ and ‘technology’ are concepts which are readily exchanged in this industry, but these are more than just buzzwords. The overall virtual clinical trials market is currently valued at $7.8 However, it also made great strides in proving the success of these sorts of trials.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

pharmaphorum

SEPTEMBER 30, 2021

Now, the FDA has published its first take on sourcing real-world data (RWD) from EHRs and medical claims, setting out its thinking on the approach that should be used to support regulatory filings for medicines.

Pharma Companies 95

Pharma Companies Regulation Clinical Trials Clinical Trials 95

pharmaphorum

JANUARY 17, 2022

The adoption of decentralised activities was a major factor in allowing clinical trials to continue during the early stages of the pandemic. Ben Hargreaves examines whether this adoption looks set to become a permanent feature of clinical trials moving into the future, rather than just supplying the tools to a temporary need.

Trials 105

Trials Clinical Trials Clinical Trials Clinical Research 105

pharmaphorum

SEPTEMBER 27, 2021

As people have become more conscious and vocal about diversity and inclusion, Page & Page’s Lisa Lishman says pharma should reassess how it conducts clinical trials. To address this problem, businesses operating in this sector should go back to the beginning of the process and look at how they conduct clinical trials.

Clinical Trials 122

Clinical Trials Clinical Trials Trials Vaccination 122

The Pharma Data

DECEMBER 23, 2020

Eligible patients enrolled in the trial receive treatment with AIM’s flagship pipeline drug Ampligen. and Daniel Peterson, MD, at Sierra Internal Medicine in Incline Village, Nev. In fact, approximately 27% of survivors in a JAMA Internal Medicine study met the U.S. All study subjects will receive the same Ampligen treatments.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drugs 52

XTalks

JANUARY 15, 2024

From the continuing trend of the rapid adoption of AI tools to the growing use of real-world evidence (RWE) in regulatory decision-making and a focus on enhancing data integrity, find out how clinical trials will evolve in 2024 to shape the future of medical research. percent from 2023 to 2033.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

pharmaphorum

OCTOBER 11, 2022

So, historically – certainly pre-2000 – if you look at the way prescription drugs were communicated, it was very tightly controlled: it was pharma companies speaking to doctors and the doctor would speak to the patient and tell them what they thought the right solution was,” he said.

Pharma Companies 98

Pharma Companies Medicine Doctors Doctor 98

The Pharma Data

SEPTEMBER 29, 2020

. Sosei Heptares has received a $5m milestone payment from its strategic alliance partner Pfizer after the first subject in a clinical trial was dosed with a new drug candidate from the collaboration between the two companies.

Clinical Trials 52

Clinical Trials Clinical Trials Pharma Companies Trials 52

World of DTC Marketing

MARCH 11, 2022

consumers’ trust in pharma is low, despite the industry’s contributions to ending the pandemic: Only 15% of U.S. consumers say they trust pharma companies more than they did before the COVID-19 pandemic, according to Accenture’s 2021 survey. What does this mean for DTC and HCP marketing?

Pharma Companies 212

Pharma Companies Vaccination Vaccine Doctors 212

pharmaphorum

OCTOBER 28, 2020

Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. Pharma remains stubbornly closed to feedback, with potentially damaging consequences for the industry, healthcare systems and patients.

Medicine 119

Medicine Pharma Companies Vaccination Vaccine 119

pharmaphorum

JANUARY 24, 2022

The UK scientists that ran one of the largest trials of experimental COVID-19 drugs have formed a non-profit company that will apply the methodology to other disease areas – with $6.8 ” Those trials also need to be large, involve a diverse range of individuals, and able to be run at reduced cost, said Landray.

Trials 97

Trials Drugs Clinical Trials Clinical Trials 97

pharmaphorum

JANUARY 27, 2023

The EMA’s human medicines committee delivered a negative opinion on palovarotene , making it very unlikely that the drug will be approved by the European Commission, although Ipsen says it will be requesting a re-examination of the marketing application.

Drugs 98

Drugs Marketing Pharma Companies Clinical Trials 98

XTalks

MAY 3, 2024

According to Real Chemistry, there are currently 119 active GLP-1 agonist clinical trials, with 53 in Phases III or IV, across more than 60 potential new indications for GLP-1 treatment.

Drugs 52

Drugs Clinical Trials Clinical Trials Marketing 52

pharmaphorum

OCTOBER 18, 2022

One of the first actions by GSK’s recently appointed chief scientific officer, Tony Wood, has been to expand a partnership with Tempus aimed at improving the big pharma’s R&D productivity, starting with its cancer pipeline. The two companies have been working together for some time.

Production 52

Production Clinical Trials Clinical Trials Genome 52

pharmaphorum

DECEMBER 15, 2021

Dialogue requires humility on the drug company’s side—accepting that sometimes we are wrong about matters we think we understand—and trust on the patients’ side that representatives of large, for-profit entities really have come to listen. When that happens, outcomes will change.

Pharma Companies 145

Pharma Companies Development Medicine Clinical Trials 145

Pharmaceutical Technology

NOVEMBER 2, 2022

The pharmaceutical community has reached somewhat of a turning point as it commercialises a growing number of speciality medicines relying on complex new treatment pathways. Nowadays, it is an active choice many pharma companies and service providers are taking. A fresh approach. It allows you to capture the benefits of both.”.

Medicine 130

Medicine Doctors Doctor Marketing 130

pharmaphorum

APRIL 22, 2021

Biosensor firm physIQ has licensed its technology to Johnson & Johnson’s Janssen pharma unit in a multi-year deal, to investigate use of wearable sensors in virtual clinical trials. It concluded that the clinical efficacy and use of the approach should be further tested, while noting its potential to reduce healthcare costs.

Licensing 72

Licensing Licensing Trials Clinical Trials 72

pharmaphorum

JANUARY 24, 2023

Through use of precision medicine and machine learning (ML), the company’s cell-centred models will aid identification of patient subtypes and pair them with personalised IBD targets. David Harel, CEO and co-founder of CytoReason, said: “It’s exciting to see the growing adoption of our technology by world-leading pharma companies.

Medicine 52

Medicine Drugs Pharma Companies Clinical Trials 52

pharmaphorum

FEBRUARY 14, 2022

In figures, this was represented by 71% of late-stage pipeline revenue being the result of the companies partnering to develop an asset. Due to the increase in funding, more biotechs and smaller scale pharma companies are able to progress assets further into clinical trials.

Production 98

Production Clinical Trials Clinical Trials Sales 98

pharmaphorum

FEBRUARY 13, 2022

BioAI is being trained on thousands of drug candidates, with the aim of helping the pharma industry discover new medicines more efficiently, and rethink how and when to best use existing drugs, according to the company. The post Merck will assess Quris’ AI ‘patient-on-a-chip’ drug safety appeared first on.

Drugs 98

Drugs In-Vivo In-Vitro Pharma Companies 98

pharmaphorum

FEBRUARY 24, 2022

Hong Kong-based Insilico Medicine has begun a Phase 1 trial of its AI-discovered and AI-designed anti-fibrotic small molecule inhibitor. . The purpose of the trial will be to determine maximum tolerated dosage and establish dosage recommendations for future trials.

Trials 40

Trials Drugs Clinical Trials Clinical Trials 40

Drug Discovery World

DECEMBER 27, 2023

Ng is working on critical challenges in clinical trials, specifically in planning and recruitment, and has been building innovative solutions designed to benefit patients and researchers – with a focus on efficiency, transparency and diversity in clinical development. Listen here. Listen here. Listen here.

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

XTalks

AUGUST 21, 2023

“The FDA approval of Sohonos is a breakthrough for the US FOP community,” said Howard Mayer, head of R&D at Ipsen, in the company’s news release. Development of medicines for rare diseases takes commitment and belief from everyone involved. Sohonos, the first and only approved drug, offers hope to those battling the disease.

Drugs 98

Drugs FDA Approval Genetics Clinical Trials 98

Drug Discovery World

AUGUST 22, 2023

Claire D’Abreau-Hayling, Chief Scientific Officer at Sandoz, examines how generic products can relieve industry pressure and improve access to essential medicines. Off-patent medicines today account for about 80% of global prescriptions at an estimated 20% of the total cost.

Production 52

Production Bioequivalency In-Vivo In-Vitro 52

XTalks

DECEMBER 20, 2023

Check out this article to learn about the biotech companies that went public this year. The companies include a diverse range engaged in innovative approaches in areas like oncology, genetic medicines, inflammatory diseases, dermatology and cardiorenal therapy.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

pharmaphorum

SEPTEMBER 11, 2020

Yet, for clinical trials worldwide, real-time access to data is not the norm – and that lack can create a cascading set of issues affecting every aspect of a study. What does this mean for clinical trials? Analysts at Pharma Intelligence decided to find out, surveying professionals involved in clinical data management.

Trials 98

Trials Clinical Trials Clinical Trials Pharma Companies 98

pharmaphorum

AUGUST 18, 2020

This is a question that a consortium of European pharma companies hopes to answer as it aims to rapidly develop new therapies to combat the pandemic. If we can find any drugs that have gone into human beings if one of those has activity against COVID-19 proteins those would make it more rapidly through clinical trials.”.

Protein 121

Protein Pharma Companies RNA Drugs 121

pharmaphorum

JUNE 7, 2022

Insilico Medicine has raised $60 million in fourth-round financing that will help to fund the advancement of more drugs towards the clinical testing stage. ” In addition to developing its own drugs, the company also works with big pharma companies including Pfizer, Johnson & Johnson, Teva and Fosun Pharma.

Clinical Trials 52

Clinical Trials Clinical Trials Drugs Pharma Companies 52